EVMN
Evommune, Inc.
NYSE · Healthcare · Biotechnology · US
$6.03
+1.52%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 65.65x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.79x
- Price / sales
- 21.88x
- Price / cash flow
- -2.95x
Enterprise value
- Enterprise value
- $26.2M
- EV / sales
- 2.62x
- EV / EBITDA
- -0.26x
- EV / EBIT
- -0.26x
- Market cap
- $218.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026